Bruker Corporation has announced its support of a worldwide collaborative project that investigates the structures, dynamics, function and binding of SARS-CoV-2 viral RNA and proteins using high-field nuclear magnetic resonance (NMR) spectroscopy. The Covid19-NMR consortium was initiated at Goethe University (GU) in Frankfurt, Germany, and leverages the extensive experience of the GU Biological Magnetic Resonance Center and of 30 consortium groups in 15 countries in high-field NMR, structural biology, and small molecule drug screening.